Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUC-1 CART in intrahepatic cholangiocarcinoma
NCT03633773Phase 2Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jul 2018
- Primary completion
- Aug 2023
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of MUC-1 CART cell in intrahepatic cholangiocarcinoma (ICC), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Status: unknown.
02
Drugs
MUC-1 CART cell
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT03633773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03633773.